[Specialties in therapy of osteoporosis in inflammatory joint disease].
The therapeutic specialties of osteoporosis in inflammatory rheumatic diseases has gained mounting interest in the last year. The paper describes special aspects of osteoporosis in rheumatoid arthritis, ankylosing spondylitis and systemic lupus erythematodes. The problems of glucocorticoid therapy are discussed intensively with regard to the recently published recommendations for glucocorticoid-induced osteoporosis. Risk factors of osteoporosis and the therapeutic implications are demonstrated intensively as well as the modifications of the recommendations.
Franck
H
H
Kreiskrankenhaus Kirchheim-Teck, Abteilung Innere Medizin, Eugenstr. 3, 73230 Kirchheim unter Teck.
Braun
J
J
Buttgereit
F
F
Dreher
R
R
Hein
G
G
Kekow
J
J
D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000628:therapy; D015519:Bone Density / Q000187:drug effects; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000628:therapy; D010024:Osteoporosis / Q000175:diagnosis / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012216:Rheumatic Diseases / Q000175:diagnosis / Q000628:therapy*; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000628:therapy
D005938:Glucocorticoids